This study tests a new drug called IDX-1197 combined with standard chemotherapy (XELOX or irinotecan) in people with advanced stomach cancer that has spread. The main goal is to find the safest dose and see if the combination helps control the cancer. About 87 adults who have not…
Phase: PHASE1, PHASE2 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC